Telix Pharmaceuticals Limited Sponsored ADR TLX 深 滬
交易中 06-25 10:39:18 美东时间
10.89
-0.010
-0.09%
華盛通- 最 高10.915
- 今 開10.83
- 成交量 2.06万股
- 最 低 10.775
- 昨 收 10.90
- 總市值 36.89亿
- 52周最高 16.98
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 6.28
- 委 比 -53.85%
- 總股本 3.39亿
- 歷史最高 30.36
- 量 比 0.90
- 振 幅 1.28%
- 歷史最低 6.28
- 每 手 1
- 風險率 2.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Telix Pharmaceuticals Signs MoU With United Imaging Healthcare North America To Evaluate A U.S. Research Collaboration On Advancing Integrated Theranostics Solutions
Partnership to evaluate Telix's innovative precision medicine products and candidates in combination with United Imaging's advanced scanner platforms.Initial focus on TLX101-Px (Pixclara®1, Floretyrosine F 18) in
06-02 19:17
Why Is Regeneron Stock Sinking Monday?
Regeneron melanoma combo trial missed its main goal against Keytruda despite longer progression-free survival in the high-dose arm.
05-18 18:28
Telix Pharma Enters Into LOI To Pursue Collaborations With EDAP And Profound Medical To Explore Investigational Use Of Telix's PSMA-PET1 Imaging Agents Gozellix And Illuccix With Robotic HIFU, And Other Image-Guided Therapies To Treat Prostate Cancer
Telix to partner with companies developing advanced minimally invasive and image-guided ablative technologies for prostate cancer.Initial focus on patient selection, treatment planning and post-treatment monitoring;
05-15 18:33
Telix Pharmaceuticals' TLX250-Px PET/CT Demonstrates High Predictive Accuracy Across All Renal Cancer Subtypes In Phase 3 ZIRCON Trial Analysis
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix") today announces the publication of a new independent analysis of Phase 3 ZIRCON trial data in European Urology1, demonstrating that TLX250-Px
05-05 05:03
Telix Pharmaceuticals To Present Safety And Tolerability Data From The ProstACT Global Phase 3 Study At ASCO 2026
MELBOURNE, Australia and INDIANAPOLIS, April 22, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix") today announces that safety and tolerability data from the ProstACT Global Phase 3
04-22 04:52
JPMorgan, Allogene Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
US stock futures mixed, Nasdaq 100 up over 50 points. JPMorgan shares down 3.1% after beating earnings but missing sales estimates. Other stocks also down in pre-market trading.
04-14 20:02
Telix Pharma Gains As Regeneron Tie-Up Targets Solid Tumor Programs
Telix collaborates with Regeneron, targeting radiopharmaceutical development, with milestones up to $2.1 billion and royalties.
04-13 20:38
Telix Seeks Reset With FDA Filing While Sales Growth Holds Steady
FDA accepts Telix NDA for Pixclara for brain cancer imaging, analysts see confidence rebuild amid steady sales growth.
04-10 21:15
美股夜盘 | Telix Pharmaceuticals Limited Sponsored ADR涨16.33%，最新股价11.4美元
Telix Pharmaceuticals Limited Sponsored ADR涨16.33%，报11.4美元
04-10 15:43
美股夜盘 | Telix Pharmaceuticals Limited Sponsored ADR涨10.00%，最新股价10.78美元
Telix Pharmaceuticals Limited Sponsored ADR涨10.00%，报10.78美元
04-10 12:22
